Tubular Apocrine Adenoma

Civatte, J; Belaïch, S; Lauret, Philippe

doi:10.1097/00000372-198000220-00025

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[6] The finding of a tubular apocrine adenoma in a female of middle age in our case is in concordance with what others have reported. [1][2][3][4][5][6][7]10,12,[14][15][16][17][18] Tubular apocrine adenoma is found most commonly on the scalp but lesions have also been described at a variety of other sites including the face, [6] eyelid, [18] axilla, [3] leg and genitalia. [4,11,17] However, Lee et al reported a case in the external auditory canal.…”

Section: Discussionmentioning

confidence: 99%

Tubular Apocrine Adenoma – A Case Report of Rare Sweat Gland Tumor

Sharma¹,

Kundal²,

Singh³

2017

Ann. Int. Med. Den.Res.

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Tubular Apocrine Adenoma – A Case Report of Rare Sweat Gland Tumor

Sharma¹,

Kundal²,

Singh³

2017

Ann. Int. Med. Den.Res.

View full text Add to dashboard Cite

show abstract

“…A connection to the epidermis or infundibulum has often been demonstrated in published cases of TA, yet these lesions were variously interpreted as PEA or TAA, not as SCAP. [1][2][3]9,14,[18][19][20][21][22][23][24][25][26][27][28] Connection of the tumors to the infundibulum has been used by some authorities as an argument to support apocrine differentiation. 2,3 One of the observers diagnosed a lesion in this series as SCAP even if it exhibited a single focus in which glandular elements were in continuity to the follicular infundibulum (Fig.…”

Section: Discussionmentioning

confidence: 99%

“…[1][2][3] The many synonyms include tubulopapillary hidardenoma, tubular syringoadenoma, and TAA or tubular adenoma (TA); the latter term has been adopted in the recent World Health Organization classification of cutaneous tumors. 4 TA was first reported by Landry and Winkelmann 5 in 1972 in association with a nevus sebaceus.…”

mentioning

confidence: 99%

Tubular Adenoma and Syringocystadenoma Papilliferum: A Reappraisal of Their Relationship. An Interobserver Study of a Series, by a Panel of Dermatopathologists

Kazakov¹,

Bisceglia²,

Calonje³

et al. 2007

The American Journal of Dermatopathology

View full text Add to dashboard Cite

Tubular adenoma (TA) and syringocystadenoma papilliferum (SCAP) may show histopathological overlap, with some lesions having features of both neoplasms (SCAP + TA). TA has been recently suggested to represent a carcinoma. Four observers blindly assessed 67 cases of TA, SCAP, and their lookalikes (poroma, apocrine adenoma, apocrine carcinoma; all lesions focally featuring a pseudopapillary pattern), and classified the lesions into one of four categories: (1) TA, (2) SCAP, (3) SCAP + TA, and (4) others. Lesions were also classified as benign or malignant. In only 29 cases was there unanimous agreement among the four observers, who classified 22 lesions as TA, three as SCAP, and four cases as others. Of the 38 cases where there was interobserver diagnostic variation, in 30, the diagnosis varied between TA or SCAP or SCAP + TA; the remainder fell in the others category. Analysis of the factors leading to interobserver variability indicated that diagnostic problems occurred when there were any of the following: epidermal acanthosis, papillomatosis, connection of the neoplastic tubules to the overlying epidermis and/or follicular infundibula, and plasma cell infiltration. These features accounted for the morphological overlap between TA and SCAP. All observers agreed that the lesions were benign; the only apocrine carcinoma included was recognized as such by all observers. From the study, it was concluded that TA may arise in the deep dermis without any epidermal connection, or, in other cases, it may be more superficially located with or without an epidermal connection. It may be reasonably inferred that, possibly as a response to infection, there may be accompanying plasma cells and variable acanthosis and papillomatosis, such that the appearances are those of "pure" SCAP, or lesions may have features "intermediate" or overlapping between TA and SCAP.

show abstract

Porphyria cutanea tarda and scleroderma-chance association or related disease: a case report

Sigal¹,

Nahum

Crickx

et al. 1990

Clin Exp Dermatol

View full text Add to dashboard Cite

The concurrence of systemic scleroderma and porphyria cutanea tarda (PCT) seems very rare. Only six cases have been reported to our knowledge. On the other hand, cutaneous sclerodermatous lesions in PCT occur more frequently and can affect 1.8-18% of cases. These observations raise the problem of a possible physiopathological relation between scleroderma and PCT. In fact, Grossman and colleagues have found anti-nuclear antibodies (ANA) in 38% of patients so tested. In the present report, the association of systemic scleroderma and PCT with Sjögren's syndrome and anti-RNP antibodies raises further questions concerning the relationship between PCT and auto-immune diseases.

show abstract

Tubular Apocrine Adenoma

Cited by 3 publications

References 0 publications

Tubular Apocrine Adenoma – A Case Report of Rare Sweat Gland Tumor

Tubular Apocrine Adenoma – A Case Report of Rare Sweat Gland Tumor

Tubular Adenoma and Syringocystadenoma Papilliferum: A Reappraisal of Their Relationship. An Interobserver Study of a Series, by a Panel of Dermatopathologists

Porphyria cutanea tarda and scleroderma-chance association or related disease: a case report

Contact Info

Product

Resources

About